Live News Categoriesmarket

XRTX.O (XRTX.O) News

Track canonical SquawkNews coverage tagged to XRTX.O, XRTX.O. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol XRTX.O Asset market Sector Markets 90 days 1 Updated Sep 18, 2026, 12:07 PM UTC Open live news feed

L XORTX plans Q4 2026 FDA IND filing for XRx — 026 gout trial using XORLO, targets USD 700 million U.S. market XORTX outlined plans to submit an FDA IND in Q4 2026 for its XRx-026 gout program using XORLO. No new trial results were presented; the program is being advanced based on supportive prior results and FDA discussions. The REGULATION | Sep 18, 2026, 12:07 PM UTC